• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SPACEOAR VUE SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SV-2101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Apnea (1720); Cardiac Arrest (1762); Loss of consciousness (2418); Diminished Pulse Pressure (2606); Syncope/Fainting (4411)
Event Date 05/25/2022
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that spaceoar vue was implanted during a spaceoar vue placement procedure performed on (b)(6) 2022.The procedure was performed under local anesthesia.After the hydrogel was placed, the patient passed out from the rectal pressure on the nerves.The patient was non responsive.Cardiopulmonary resuscitation (cpr) was administered.The patient was transferred to the emergency department (ed) and was intubated.The patient also tested positive for covid-19 again.On (b)(6) 2022 the patient was extubated, and released.
 
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.Block h6: clinical code e0119 captures the reportable event of loss of consciousness.Evaluation conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the device remains implanted and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Correction: it was noticed on june 23, 2022, that the following patient codes 9235: pulse, loss of and 9018: apnea was not included in the initial mdr report.
 
Event Description
It was reported to boston scientific corporation that spaceoar vue was implanted during a spaceoar vue placement procedure performed on (b)(6) 2022.The procedure was performed under local anesthesia.After the hydrogel was placed, the patient passed out from the rectal pressure on the nerves.The patient was non responsive.Cardiopulmonary resuscitation (cpr) was administered.The patient was transferred to the emergency department (ed) and was intubated.The patient also tested positive for covid-19 again.On (b)(6) 2022 the patient was extubated, and released.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.Block h6: clinical code e0119 captures the reportable event of loss of consciousness.Block h11: block h6 patient and impact codes have been corrected.
 
Event Description
It was reported to boston scientific corporation that spaceoar vue was implanted during a spaceoar vue placement procedure performed on (b)(6) 2022.The procedure was done under local anesthesia.It was reported that after the gel was placed, the patient passed out from the rectal pressure on the nerves.The patient was non responsive.Cardiopulmonary resuscitation (cpr) was administered.The patient was transferred to the emergency department and was intubated.The patient also tested positive for covid-19 again.The patient was extubated on (b)(6) 2022, and had already been released.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR VUE SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORK LIMITED
500 commander shea boulevard
quincy MA 02171
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14718991
MDR Text Key294542612
Report Number3005099803-2022-03317
Device Sequence Number1
Product Code OVB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K182971
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSV-2101
Device Catalogue NumberSV-2101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/25/2022
Initial Date FDA Received06/16/2022
Supplement Dates Manufacturer Received06/23/2022
06/13/2023
Supplement Dates FDA Received07/19/2022
06/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-